The resolution urges the United States Congress to deschedule marijuana from its current classification as a Schedule I controlled substance under the federal Controlled Substances Act (CSA). This classification implies that marijuana has a high potential for abuse, lacks accepted medical use, and poses safety risks under medical supervision. However, the resolution highlights that marijuana has been legalized for both recreational and medical use in New Jersey, supported by the Jake Honig Compassionate Use Medical Cannabis Act, which recognizes its medical benefits for various conditions. Furthermore, 37 other states and numerous public health institutions have acknowledged the therapeutic value of cannabis, which contradicts its Schedule I status.

The resolution emphasizes the negative implications of marijuana's current classification, including restrictions on financial services for dispensaries, lack of insurance coverage for medical marijuana patients, and increased safety risks due to cash-heavy operations. It argues that descheduling marijuana is essential to protect the health and safety of New Jersey residents and to align federal policy with evolving public opinion and scientific research regarding cannabis use. The resolution calls for Congress to take action to modify marijuana's classification to better reflect its accepted medical uses and to alleviate the challenges faced by the cannabis industry and its consumers.